Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis
Open Access
- 18 June 2021
- journal article
- research article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (3) , e20210017
Abstract
To identify microorganisms in sputum samples of patients with stable non-cystic fibrosis bronchiectasis and to determine risk factors related to the isolation of Pseudomonas aeruginosa (PA) in those patients. Consecutive patients were recruited from a tertiary hospital outpatient clinic in the city of Fortaleza, Brazil. The patients were submitted to spirometry, six-minute walk test, HRCT, and sputum collection. Data on serum fibrinogen levels, disease severity, sputum color, and history of azithromycin treatment were collected. The study included 112 patients, and females predominated (68%). The mean age was 51.6 ± 17.4 years. Most patients presented with mild-to-moderate disease (83%). The mean six-minute walk distance was 468.8 ± 87.9 m. Mean FEV1 and FVC, in % of predicted values, were 60.4 ± 21.8% and 69.9 ± 18.5%, respectively. The mean serum fibrinogen level was 396.1 ± 76.3 mg/dL. PA was isolated in 47 patients, other potentially pathogenic microorganisms (PPMs) were isolated in 31 patients, and non-PPMs were isolated in 34 patients. Purulent sputum was identified in 77 patients (68%). The patients with PA, when compared with those without it, presented with more severe disease, higher serum fibrinogen levels, and lower FVC%. In addition, purulent sputum and long-term azithromycin treatment were more common in those with PA. The multivariate regression analysis showed that the independent factors associated with PA were serum fibrinogen level > 400 mg/dL (OR = 3.0; 95% CI: 1.1-7.7) and purulent sputum (OR = 4.3; 95% CI: 1.6-11.3). In our sample, the prevalence of PA in sputum was 42%. Sputum color and inflammatory markers were able to predict the isolation of PA, emphasizing the importance of routine sputum monitoring.Keywords
This publication has 25 references indexed in Scilit:
- Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED scoreEuropean Respiratory Journal, 2013
- Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota compositionThorax, 2013
- Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasisEuropean Respiratory Journal, 2009
- Relation of sputum colour to bacterial load in acute exacerbations of COPDRespiratory Medicine, 2009
- BronchiectasisChest, 2008
- Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis BronchiectasisChest, 2007
- Microbiologic follow-up study in adult bronchiectasisRespiratory Medicine, 2007
- Pulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosisJournal of Allergy and Clinical Immunology, 2006
- Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factorsThorax, 2002